APA (7th ed.) Citation

Lehrer-Graiwer, J., Howard, J., Hemmaway, C. J., Awogbade, M., Telfer, P., Layton, M., . . . Ramos, E. (2016). Long-Term Dosing in Sickle Cell Disease Subjects with GBT440, a Novel HbS Polymerization Inhibitor. Blood, 128(22), 2488. https://doi.org/10.1182/blood.V128.22.2488.2488

Chicago Style (17th ed.) Citation

Lehrer-Graiwer, Josh, et al. "Long-Term Dosing in Sickle Cell Disease Subjects with GBT440, a Novel HbS Polymerization Inhibitor." Blood 128, no. 22 (2016): 2488. https://doi.org/10.1182/blood.V128.22.2488.2488.

MLA (9th ed.) Citation

Lehrer-Graiwer, Josh, et al. "Long-Term Dosing in Sickle Cell Disease Subjects with GBT440, a Novel HbS Polymerization Inhibitor." Blood, vol. 128, no. 22, 2016, p. 2488, https://doi.org/10.1182/blood.V128.22.2488.2488.